Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
-
New shot tested to tame severe childhood eczema
Disease control OngoingThis study is testing a new injectable drug called 611 in Chinese children and teenagers with moderate to severe atopic dermatitis (eczema). The main goals are to check if the drug is safe, how it moves through the body, and if it can reduce the severity of skin symptoms and itch…
Phase: PHASE1, PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New asthma drug aims to tame severe attacks
Disease control OngoingThis study is testing an investigational antibody drug for adults with a specific type of severe asthma. The goal is to see if adding this drug to standard care can help people breathe better and have fewer serious asthma attacks over a year. About 225 participants will receive e…
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for stubborn sinus problems? drug trial targets nasal polyps
Disease control OngoingThis study is testing whether an investigational drug called 611, when added to a standard nasal spray, can better control chronic sinusitis with nasal polyps in adults. It aims to reduce polyp size, ease nasal blockage, and improve smell and quality of life for people whose cond…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC